Cargando…
Adrenocortical suppression and recovery after continuous hypnotic infusion: etomidate versus its soft analogue cyclopropyl-methoxycarbonyl metomidate
INTRODUCTION: Etomidate is no longer administered as a continuous infusion for anesthetic maintenance or sedation, because it results in profound and persistent suppression of adrenocortical steroid synthesis with potentially lethal consequences in critically ill patients. We hypothesized that rapid...
Autores principales: | Ge, Rile, Pejo, Ervin, Cotten, Joseph F, Raines, Douglas E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057162/ https://www.ncbi.nlm.nih.gov/pubmed/23363638 http://dx.doi.org/10.1186/cc12494 |
Ejemplares similares
-
Minimum infusion rate and adrenocortical function after continuous infusion of the novel etomidate analog ET-26-HCl in rats
por: Jiang, Junli, et al.
Publicado: (2017) -
Masked volume wise principal component analysis of small adrenocortical tumours in dynamic [11C]-metomidate positron emission tomography
por: Razifar, Pasha, et al.
Publicado: (2009) -
E161111 is an ultra-short-acting etomidate analogue with stable haemodynamics that elicits only slight adrenocortical suppression in rats
por: Wang, Bin, et al.
Publicado: (2022) -
Effects of continuous infusion of etomidate at various dose rates on adrenal function in dogs
por: Qin, Bangyong, et al.
Publicado: (2016) -
Continuous Etomidate Infusion for the Management of Severe Cushing Syndrome: Validation of a Standard Protocol
por: Carroll, Ty B, et al.
Publicado: (2018)